Kala Bio (KALA) Other Accumulated Expenses (2016 - 2026)
Kala Bio (KALA) recorded Other Accumulated Expenses of $41,000 in Q2 2026, down 90.6% from $436,000 a year earlier.
Powered by 
Analysis
Kala Bio (KALA) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
At the end of FY2025, Kala Bio reported Other Accumulated Expenses of $104,000, down 74.8% from FY2024.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $413,000 in FY2024 (+8.7%), $380,000 in FY2023 (-36.1%), $595,000 in FY2022 (-91.5%) and $7.01 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Other Accumulated Expenses in data going back to Q4 2016.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 92.7% in Q1 2022, against a decline of 91.5% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kala Bio | 5.81 Mn | 5.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 436,000.00 |
| Dec 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 595,000.00 |
| Sep 30, 2022 | 422,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 7.01 Mn |
| Sep 30, 2021 | 554,000.00 |
| Jun 30, 2021 | 550,000.00 |
| Mar 31, 2021 | 523,000.00 |
| Dec 31, 2020 | 552,000.00 |
| Sep 30, 2020 | 620,000.00 |
| Jun 30, 2020 | 180,000.00 |
| Mar 31, 2020 | 465,000.00 |
| Dec 31, 2019 | 1.03 Mn |
API Access
Kala Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();